Prot #NU 15U06: A Phase 1 Dose-Escalation Study of Intravesical MK-3475 and Bacillus Calmette-Guerin (BCG) in Subjects with High Risk and BCG-Refractory Non-Muscle-Invasive Bladder Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date10/14/1610/14/22

Funding

  • Merck Sharp & Dohme Corporation (Prot #NU 15U06)